0 Comments
0 Shares
629 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
North America segment contributes over 35% of global buprenorphine market shareMarket Overview: The global buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2022 and is expected to exhibit a CAGR of 14.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Buprenorphine is a partial opioid agonist used to treat opioid addiction and pain. It provides an effective alternative to methadone for...0 Comments 0 Shares 2K Views 0 Reviews
-
Opioid Addiction Treatment Market To Witness High Growth Driven By Expanding Patient Base And Increasing R&D ActivitiesBuprenorphine is an opioid medication primarily used to treat opioid use disorder, acute pain, and chronic pain. It is typically taken under the tongue as a film, tablet, or as an injection. Buprenorphine helps to relieve cravings and withdrawal symptoms associated with opioid addiction. The medication works by activating opioid receptors in the brain to relieve pain and reduce opioid cravings...0 Comments 0 Shares 1K Views 0 Reviews